March 2021 - Page 28 of 43

WednesdayMar 10, 2021 11:48 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Collaborates to Advance Commercialization of Patented UST Platform

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life science and other industries, together with the College of Food, Agricultural and Environmental Sciences (“CFAES”) at Ohio State University, recently announced a strategic agreement for the implementation of PBI’s patented Ultra Shear Technology(TM) (“UST”) platform. PBI is developing three different models of the UST processing instrument, named the BaroShear. All three designs, including a small footprint benchtop model, a medium capacity floor model and an industrial scale, continuous flow model for high capacity, are engineered to perform high shear processing of liquids under controlled temperatures…

WednesdayMar 10, 2021 11:25 am

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Empowers Clients with On-Demand Products

InsuraGuest Technologies (TSXV: ISGI) (OTCQB: ISGIF), an innovative insurtech (insurance+technology) company, is engaged in delivering digital insurance to multiple sectors through its proprietary software platform. InsuraGuest harnesses the power of technology to deliver digital offerings across all sectors, empowering clients with on-demand insurance products. A recent article discussing this reads, “The hotels and rental properties who enroll in the InsuraGuest Hospitality Liability coverages require their guests to pay a nominal fee at the time of check-in. InsuraGuest then pays out these small claims, shifting the burden from the hotel operator. With no surge in premium prices, there is no impact…

WednesdayMar 10, 2021 11:17 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Leverages ‘Absolute Powerhouse Compound’ as IND Status Paves Way for Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco, in a recent podcast, showed his excitement at news that the U.S. Food and Drug Administration (“FDA”) had granted Berubicin investigational new drug (“IND”) status. The IND designation clears the way for the company to start human clinical trials and to ship the experimental drug across state lines to clinical investigators. “This is the biggest news we’ve announced since our IPO back in November 2019,” Climaco said of the significant milestone. “Based on that IND approval, we expect, in the next 90 to 120 days, we will go from zero active clinical trials…

WednesdayMar 10, 2021 11:10 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Emerging Growth Virtual Conference

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that its CEO James Sapirstein will present at the virtual Maxim Group Emerging Growth Virtual Conference. The two-day conference is slated for March 17–18, 2021. During the online event, all registered attendees will be able to access Sapirstein’s presentation on demand. The presentation will include an overview of AzurRx BioPharma, including its business and clinical-development programs; Sapirstein will also talk about goals and accomplishments the company is working toward in 2021. Following the presentation, Sapirstein and other members of the AzurRx management team will…

WednesdayMar 10, 2021 10:38 am

QualityStocksNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) to Host Q4 and Full-Year 2020 Results Conference Call

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, today announced that it will hold a conference call to discuss its results for the four quarter and year ended December 31, 2020. The call, to be hosted by Sigma Labs president and CEO Mark Ruport and CFO Frank Orzechowski, is scheduled to take place at 4:30 p.m. Eastern Time on Wednesday, March 24, 2021, followed by a question-and-answer period. Interested parties can access the call by dialing 1-877-407-9039 (Toll-Free) or 1-201-689-8470 (International) and entering conference ID: 13717059. The conference call will…

WednesdayMar 10, 2021 10:38 am

QualityStocksNewsBreaks – Mobius Interactive Inc. Announces Appointment of New VP with Deep Investor Relations, Corporate Development Expertise

Mobius Interactive has appointed a new vice president and board member. Effective immediately Seamus Byrne will take over his new responsibilities, bringing his extensive insight and expertise to bear as he focuses on helping the nascent company achieve its mission. Byrne has more than three decades of capital market experience in both the private and public sectors, gathering a wealth of corporate development knowledge and insight along the way. He has led the development and operations of several different organizations and has played a key role in raising more than C$100 million; he has also driven market capitalizations for public…

WednesdayMar 10, 2021 10:15 am

Companies Look to SRAX Inc. (NASDAQ: SRAX) to Maximize Analytics Insight Capabilities

Data, not time, is now a company’s most valuable asset Investing in analytics leads to a host of benefits, including higher growth SRAX’s innovative Sequire technology unlocks stock buyers’ behaviors, trends for issuers of publicly traded companies Today, businesses need every piece of leverage available in order to compete and maximize corporate efficiencies. Efficiency is underscored by ranking and managing resources—a task that can be a moving target based on trends. Seven years ago, Harvard Business Review made the case that time was a company’s most valuable commodity. In 2017, The Economist contested that data was the world’s – not…

WednesdayMar 10, 2021 10:11 am

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Resignation of Outside Director

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, today announced the resignation of John M. Hollister. Hollister served as the company’s CEO prior to its reverse acquisition by Grapefruit Boulevard Investments as well as its transition from a developer of 3D imaging to a fully licensed manufacturer and distributor of cannabis products. These include Grapefruit’s patented, disruptive Hourglass(TM) time-release THC/cannabinoid delivery cream. “We are pleased that the previous chapter of the Imaging3/Grapefruit saga has come to an amicable conclusion. While we, of course, will devote the vast majority of our time and energy to our rapidly growing…

WednesdayMar 10, 2021 9:57 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announced Partner Has Received ISO Certification for Rapid COVID-19 Test

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has announced that 3a-diagnostics GmbH ("3a") has received EN ISO 13485 certification for its rapid point-of-care, SARS-CoV-2 RT-PCR Test System ("Covid-ID Lab"). 3a-diagnostics is XPhyto’s exclusive German diagnostics development partner. In addition the company expects CE-IVD approval for the product this month. These two approvals will allow 3a-diagnostics GmbH to distribute the Covid-ID Lab. The EN ISO approval is the internationally recognized European standard for quality control and management systems in the category of design and manufacture of…

Site Search

Company Search

Month: March 2021